Physician profile
Judith Wilson
NPI 1164453932
$1,141.23
in general payments reported to CMS, 2019-2025
20 companies · $17.55 in 2025
The $17.55 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $245 · 2020: $220 · 2021: $168 · 2022: $362 · 2023: $113 · 2024: $16.39 · 2025: $17.55.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $147.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $146.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $291.03 | 2019-2023 | Otezla, Repatha |
| Abbvie INC. | $190.77 | 2021-2023 | Ubrelvy |
| Novo Nordisk INC | $123.41 | 2019-2023 | Rybelsus, Ozempic |
| Teva Pharmaceuticals USA, INC. | $70.95 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $64.75 | 2019-2022 | |
| Lilly USA, LLC | $63.77 | 2019-2023 | Mounjaro, Jardiance, Emgality |
| Biohaven Pharmaceutical Holding Company LTD. | $54.36 | 2022 | |
| Janssen Pharmaceuticals, INC | $41.03 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $35.46 | 2020-2022 | |
| Radius Health, INC. | $29.07 | 2019-2020 | |
| Glaxosmithkline, LLC. | $27.34 | 2019-2021 | |
| Alkermes, INC. | $24.86 | 2020 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $21.16 | 2022 | |
| Inspire Medical Systems, INC. | $17.55 | 2025 | Inspire |
| Corcept Therapeutics | $16.39 | 2024 | Korlym |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $14.63 | 2021 | |
| Merck Sharp & Dohme LLC | $14.21 | 2019 | |
| Pfizer INC. | $14.09 | 2019 | |
| Dexcom, INC. | $13.59 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $12.81 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Judith Wilson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.